StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Management ChangeJul 31, 2026, 04:14 PM

Silexion Therapeutics Director Professor Amnon Peled Resigns

AI Summary

Silexion Therapeutics Corp announced that Professor Amnon Peled has resigned from its Board of Directors, effective August 1, 2026. The company stated that his departure was due to personal reasons and did not arise from any disagreement with the company's operations, policies, or practices.

Key Highlights

  • Professor Amnon Peled resigned from the Board of Directors of Silexion Therapeutics Corp.
  • The resignation is effective as of August 1, 2026.
  • Professor Peled cited personal reasons for his departure.
  • His resignation did not stem from any disagreement with the company's operations, policies, or practices.